Dapansutrile and its Impurities

Dapansutrile (also known as OLT1177) is an investigational drug that is an orally administered, selective inhibitor of the NLRP3 inflammasome. The drug is being developed by Olatec Therapeutics and is currently in clinical trials. Reference standards of Dapansutrile API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.